RTA Laboratuvarlari Biyolojik Asset Resilience Ratio

Latest as of June 2025: 0.21%

RTA Laboratuvarlari Biyolojik asset resilience ratio. RTA Laboratuvarlari Biyolojik (RTALB) has an Asset Resilience Ratio of 0.21% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See RTA Laboratuvarlari Biyolojik liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

TL4.69 Million

≈ $105.07K USD Cash + Short-term Investments

Total Assets

TL2.23 Billion

≈ $49.90 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of RTA Laboratuvarlari Biyolojik (2016–2024)

Asset resilience ratio of RTA Laboratuvarlari Biyolojik from 2016 to 2024. This chart shows how RTA Laboratuvarlari Biyolojik's Asset Resilience Ratio has changed over time. Read how much debt does RTA Laboratuvarlari Biyolojik carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down RTA Laboratuvarlari Biyolojik's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see RTA Laboratuvarlari Biyolojik balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	TL0.00	0%
Short-term Investments	TL4.69 Million	0.21%
Total Liquid Assets	TL4.69 Million	0.21%

Asset Resilience Insights

Limited Liquidity: RTA Laboratuvarlari Biyolojik maintains only 0.21% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

RTA Laboratuvarlari Biyolojik Industry Peers by Asset Resilience Ratio

Compare RTA Laboratuvarlari Biyolojik's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	15.21%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Immunovant Inc NASDAQ:IMVT	Biotechnology	98.50%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Amicus Therapeutics Inc NASDAQ:FOLD	Biotechnology	8.37%

RTA Laboratuvarlari Biyolojik Asset Resilience Ratio by Year (2016–2024)

RTA Laboratuvarlari Biyolojik asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for RTA Laboratuvarlari Biyolojik.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.23%	TL4.47 Million ≈ $100.14K	TL1.92 Billion ≈ $43.03 Million	-5.38pp
2023-12-31	5.61%	TL101.20 Million ≈ $2.27 Million	TL1.80 Billion ≈ $40.42 Million	-10.34pp
2022-12-31	15.95%	TL118.08 Million ≈ $2.64 Million	TL740.21 Million ≈ $16.58 Million	+14.89pp
2021-12-31	1.06%	TL5.86 Million ≈ $131.31K	TL552.40 Million ≈ $12.37 Million	+0.70pp
2020-12-31	0.36%	TL916.80K ≈ $20.53K	TL256.52 Million ≈ $5.75 Million	+0.28pp
2018-12-31	0.08%	TL51.38K ≈ $1.15K	TL66.05 Million ≈ $1.48 Million	-2.61pp
2017-12-31	2.69%	TL1.70 Million ≈ $38.01K	TL63.09 Million ≈ $1.41 Million	-0.16pp
2016-12-31	2.85%	TL1.73 Million ≈ $38.85K	TL60.89 Million ≈ $1.36 Million	--

pp = percentage points

About RTA Laboratuvarlari Biyolojik

IS:RTALB Turkey Biotechnology

Market Cap

$22.17 Million

TL990.00 Million TRY

Market Cap Rank

#24593 Global

#387 in Turkey

Share Price

TL1.98

Change (1 day)

+0.51%

52-Week Range

TL1.86 - TL4.71

All Time High

TL29.60